"Interferon-Release Assays, Igras) Test Set" Property Procurement Case

TaiwanTenders notice for "Interferon-Release Assays, Igras) Test Set" Property Procurement Case. The reference ID of the tender is 124250183 and it is closing on 19 Aug 2025.

100% Secure Payments

Tender Details

  • Country: Taiwan
  • Summary: "Interferon-Release Assays, Igras) Test Set" Property Procurement Case
  • TWT Ref No: 124250183
  • Deadline: 19 Aug 2025
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: 9898000
  • Notice Type: Tender
  • Document Ref. No.: TBC-1140215
  • Purchaser's Detail :
  • Purchaser : HYGIENE AND WELFARE DEPARTMENT THORACIC HOSPITAL
    Office address: 717 No. 864, Zhongshan Road, Rende District, Tainan City
    Contact person: Huang Minyue
    Contact number: (06) 2705911 #3222
    Fax number: (06) 270340061549914d65604307a34fd1855292577
    Email :tn50190@ccd.mohw.gov.tw

  • Description :
  • "Interferon-release assays, IGRAs) test set" property procurement case
    Target category: Property 352 - Pharmaceutical products61549914d65604307a34fd1855292577
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
TaiwanTenders Features

TaiwanTenders Features

Fresh and verified Tenders from Taiwan. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Taiwan in your email inbox.

  Chat with us